Author: Damrongsak Faroongsarng
Publisher: Adis International
ISSN: 1173-2563
Source: Clinical Drug Investigation, Vol.24, Iss.11, 2004-01, pp. : 681-688
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Rojpibulstit M. Kasiwong S. Juthong S. Phadoongsombat N. Faroongsarng D.
Clinical Drug Investigation, Vol. 23, Iss. 4, 2003-01 ,pp. :
By Paleari Davide Rossi Giovanni A Nicolini Gabriele Olivieri Dario
Expert Opinion on Drug Discovery, Vol. 6, Iss. 11, 2011-11 ,pp. :
By Zheng Xin Yang Rui Zhang Yu Wang Zhijun Tang Xing Zheng Liangyuan
Drug Development and Industrial Pharmacy, Vol. 33, Iss. 7, 2007-07 ,pp. :
A Benefit-Risk Review of Systemic Haemostatic Agents: Part 1: In Major Surgery
Drug Safety, Vol. 31, Iss. 3, 2008-01 ,pp. :